An interventional study of Oncostatin M in Ulcerative Colitis, sponsored by Beni-Suef University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-08-03.
Sponsored by Beni-Suef University · Not applicable, Interventional, and Diagnostic
Ulcerative colitis (UC) is a refractory disease characterized by symptoms such as diarrhea, bloody stools, and abdominal pain with repeated relapses and remissions.
Evaluation of UC activity is important, and endoscopic evaluations of mucosal inflammation can facilitate subsequent prognostication. On the basis of these considerations, achievement of mucosal healing is important in inflammatory bowel disease (IBD), and evaluation of IBD using endoscopy is extremely important. However, endoscopic examinations are associated with problems such as physical burden to the patient, cost, and risk of complications.
Thus, to avoid the need for frequent endoscopy, noninvasive biomarkers that accurately reflect the endoscopic activity of UC have emerged, and fecal calprotectin (FC) and the fecal immunochemical occult blood test (FIT) are being widely used in clinical practice.
1,073 studies on the registry are indexed under Colitis; 131 are open to participants now.
This study's planned enrollment of 99 is above the median of 60 across 771 interventional studies indexed under Colitis.
Browse Colitis studies →Beni-Suef University is the lead sponsor of 333 studies on the registry; 116 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
45 Patients with UC. The diagnosis of UC will be based on endoscopic finding and histopathological finding
Diagnostic Test: Oncostatin M
45 apparently healthy subjects as controls who were not UC
Diagnostic Test: Oncostatin M
Test to diagnosis of Ulcerative colitis
Identify if oncostatin M is a good marker
Diagnosis of Ulcerative colitis and follow up
Time frame: 6 months
No study locations are listed for this record.
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beni-Suef University